Celltrion Healthcare targets top end for $882m IPO
Celltrion Healthcare is on track to raise W1tr ($882.4m) as it eyes the top of guidance for its IPO, taking advantage of strong demand from international long-only funds, according to a source close to the deal.
The marketing affiliate of South Korean drug maker Celltrion was set to wrap up bookbuilding for its IPO at 5pm, Hong Kong time on Friday and price the deal shortly after.
The float comprised 24.6m primary shares
, which the company was offering at W32,500-W41,000 apiece, giving it
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: firstname.lastname@example.org or find out more online here.